Monday, 26 January 2015
Last updated 8 hours ago
Jan 20 2011 | 2:59am ET
More than a dozen top medical research journals are to consider requiring authors to disclose payments from hedge funds and other investment firms.
The move by the New England Journal of Medicine, Journal of the American Medical Association, The Lancet and 11 other publications follows the arrest of a doctor for allegedly passing confidential information about a drug trial to hedge fund FrontPoint Partners. Yves Benhamou was an adviser to the drug market, Human Genome Sciences, as well as to several hedge funds.
The 14 members of the International Committee of Medical Journal Editors will discuss a possible disclosure requirement at their annual meeting in June. Researchers are already required to disclose financial relationships with drug and medical device makers.
Medical journals are scoured by health-care investors, and articles can have a major impact on the market.
Jan 23 2015 | 1:00pm ET
In our new section, FINtech Focus, we will profile one of these firms each week. While fintech is a broad category, we will be focusing on firms that specifically cater to the alternative investment industry. Read more…